Natural Alternatives International Inc. (NAII) — 分析摘要
Natural Alternatives International Inc.(NAII)的市值为7.64百万美元,最近一年的营收同比增长了+9.7%。净利润率为-14.5%。当前市盈率为-0.4倍。
核心要点
- 营收同比变化+9.7%
- 净利润率-14.5%
- 市盈率-0.4倍
与MEDICINAL CHEMICALS & BOTANICAL PRODUCTS板块的其他公司相比,NAII的营收增长为+9.7%,市盈率为-0.4倍。
Natural Alternatives International Inc. (NAII)
前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR
红旗与风险提示高风险信号
存在多项实质性红旗,在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 -15.8x — 盈利不足以覆盖利息支出
营业利润率为 -13.2% — 经营亏损显著
最新报表显示自由现金流为负。
Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. It has two segments Private-label contract manufacturing, and Patent and trademark licensing. Majority of revenue comes from Private-label contract manufacturing. Majority of revenue comes from United States.
行业
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
员工人数
230
总部
CARLSBAD, CA
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。